Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Parkinson disease protein 7 homolog) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1)

 PARK7_MOUSE             Reviewed;         189 AA.
Q99LX0; O88306; Q3THB9; Q3U509;
07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
01-JUN-2001, sequence version 1.
25-OCT-2017, entry version 134.
RecName: Full=Protein/nucleic acid deglycase DJ-1 {ECO:0000250|UniProtKB:Q99497};
EC=3.1.2.- {ECO:0000250|UniProtKB:Q99497};
EC=3.5.1.- {ECO:0000250|UniProtKB:Q99497};
EC=3.5.1.124 {ECO:0000250|UniProtKB:Q99497};
AltName: Full=Maillard deglycase {ECO:0000250|UniProtKB:Q99497};
AltName: Full=Parkinson disease protein 7 homolog {ECO:0000305};
AltName: Full=Parkinsonism-associated deglycase {ECO:0000250|UniProtKB:Q99497};
AltName: Full=Protein DJ-1 {ECO:0000305};
Short=DJ-1;
Flags: Precursor;
Name=Park7 {ECO:0000312|MGI:MGI:2135637};
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Kidney;
PubMed=11223268; DOI=10.1016/S0378-1119(00)00590-4;
Taira T., Takahashi K., Kitagawa R., Iguchi-Ariga S.M.M., Ariga H.;
"Molecular cloning of human and mouse DJ-1 genes and identification of
Sp1-dependent activation of the human DJ-1 promoter.";
Gene 263:285-292(2001).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=BALB/cJ, and NOD; TISSUE=Thymus;
PubMed=16141072; DOI=10.1126/science.1112014;
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
Hayashizaki Y.;
"The transcriptional landscape of the mammalian genome.";
Science 309:1559-1563(2005).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=C57BL/6J;
PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
Lindblad-Toh K., Eichler E.E., Ponting C.P.;
"Lineage-specific biology revealed by a finished genome assembly of
the mouse.";
PLoS Biol. 7:E1000112-E1000112(2009).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=FVB/N; TISSUE=Mammary tumor;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
PROTEIN SEQUENCE OF 13-27; 63-89 AND 99-122, AND IDENTIFICATION BY
MASS SPECTROMETRY.
TISSUE=Hippocampus;
Lubec G., Klug S.;
Submitted (MAR-2007) to UniProtKB.
[6]
INDUCTION.
PubMed=14749723; DOI=10.1038/sj.embor.7400074;
Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K.,
Ariga H.;
"DJ-1 has a role in antioxidative stress to prevent cell death.";
EMBO Rep. 5:213-218(2004).
[7]
FUNCTION, AND DISRUPTION PHENOTYPE.
PubMed=15784737; DOI=10.1073/pnas.0501282102;
Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S.,
Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D.,
Lozano A.M., Anisman H., Park D.S., Mak T.W.;
"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyrindine (MPTP) and oxidative stress.";
Proc. Natl. Acad. Sci. U.S.A. 102:5215-5220(2005).
[8]
FUNCTION, AND DISRUPTION PHENOTYPE.
PubMed=17015834; DOI=10.1073/pnas.0607260103;
Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P.;
"DJ-1, a cancer- and Parkinson's disease-associated protein,
stabilizes the antioxidant transcriptional master regulator Nrf2.";
Proc. Natl. Acad. Sci. U.S.A. 103:15091-15096(2006).
[9]
FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF CYS-46; CYS-53 AND
CYS-106.
PubMed=17766438; DOI=10.1073/pnas.0703219104;
Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B.,
Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H.,
Przedborski S., Dawson T.M., Dawson V.L.;
"DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-
like peroxidase.";
Proc. Natl. Acad. Sci. U.S.A. 104:14807-14812(2007).
[10]
FUNCTION.
PubMed=19276172; DOI=10.1096/fj.08-125153;
Waak J., Weber S.S., Waldenmaier A., Gorner K., Alunni-Fabbroni M.,
Schell H., Vogt-Weisenhorn D., Pham T.T., Reumers V., Baekelandt V.,
Wurst W., Kahle P.J.;
"Regulation of astrocyte inflammatory responses by the Parkinson's
disease-associated gene DJ-1.";
FASEB J. 23:2478-2489(2009).
[11]
FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
PubMed=20800516; DOI=10.1016/j.bcmd.2010.07.014;
Xu X., Martin F., Friedman J.S.;
"The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in
red cells and plays a role in protection against oxidative damage.";
Blood Cells Mol. Dis. 45:227-232(2010).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
Pancreas, Spleen, and Testis;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and
expression.";
Cell 143:1174-1189(2010).
[13]
INTERACTION WITH BBS1; CLCF1; MTERF AND OTUD7B.
PubMed=21097510; DOI=10.1074/jbc.M110.147371;
McNally R.S., Davis B.K., Clements C.M., Accavitti-Loper M.A.,
Mak T.W., Ting J.P.;
"DJ-1 enhances cell survival through the binding of cezanne, a
negative regulator of NF-{kappa}B.";
J. Biol. Chem. 286:4098-4106(2011).
[14]
FUNCTION, AND DISRUPTION PHENOTYPE.
PubMed=21068725; DOI=10.1038/nature09536;
Guzman J.N., Sanchez-Padilla J., Wokosin D., Kondapalli J., Ilijic E.,
Schumacker P.T., Surmeier D.J.;
"Oxidant stress evoked by pacemaking in dopaminergic neurons is
attenuated by DJ-1.";
Nature 468:696-700(2010).
[15]
FUNCTION, AND DISRUPTION PHENOTYPE.
PubMed=20186336; DOI=10.1371/journal.pone.0009367;
Krebiehl G., Ruckerbauer S., Burbulla L.F., Kieper N., Maurer B.,
Waak J., Wolburg H., Gizatullina Z., Gellerich F.N., Woitalla D.,
Riess O., Kahle P.J., Proikas-Cezanne T., Kruger R.;
"Reduced basal autophagy and impaired mitochondrial dynamics due to
loss of Parkinson's disease-associated protein DJ-1.";
PLoS ONE 5:E9367-E9367(2010).
[16]
FUNCTION, AND CAUTION.
PubMed=22523093; DOI=10.1093/hmg/dds155;
Lee J.Y., Song J., Kwon K., Jang S., Kim C., Baek K., Kim J., Park C.;
"Human DJ-1 and its homologs are novel glyoxalases.";
Hum. Mol. Genet. 21:3215-3225(2012).
[17]
FUNCTION, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, AND DISRUPTION
PHENOTYPE.
PubMed=22611253; DOI=10.1093/jmcb/mjs025;
Jain D., Jain R., Eberhard D., Eglinger J., Bugliani M., Piemonti L.,
Marchetti P., Lammert E.;
"Age- and diet-dependent requirement of DJ-1 for glucose homeostasis
in mice with implications for human type 2 diabetes.";
J. Mol. Cell Biol. 4:221-230(2012).
[18]
FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
PubMed=23847046; DOI=10.1093/hmg/ddt332;
Kim K.S., Kim J.S., Park J.Y., Suh Y.H., Jou I., Joe E.H., Park S.M.;
"DJ-1 associates with lipid rafts by palmitoylation and regulates
lipid rafts-dependent endocytosis in astrocytes.";
Hum. Mol. Genet. 22:4805-4817(2013).
[19]
FUNCTION.
PubMed=23792957; DOI=10.1074/jbc.M113.482091;
Bjorkblom B., Adilbayeva A., Maple-Grodem J., Piston D., Okvist M.,
Xu X.M., Brede C., Larsen J.P., Moller S.G.;
"Parkinson disease protein DJ-1 binds metals and protects against
metal-induced cytotoxicity.";
J. Biol. Chem. 288:22809-22820(2013).
[20]
ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, SUCCINYLATION [LARGE
SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY MASS SPECTROMETRY
[LARGE SCALE ANALYSIS].
TISSUE=Embryonic fibroblast;
PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
"SIRT5-mediated lysine desuccinylation impacts diverse metabolic
pathways.";
Mol. Cell 50:919-930(2013).
[21]
FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH NCF1.
PubMed=26021615; DOI=10.1038/cr.2015.63;
Liu W., Wu H., Chen L., Wen Y., Kong X., Gao W.Q.;
"Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS
production and protect against sepsis.";
Cell Res. 25:691-706(2015).
[22]
FUNCTION, AND DISRUPTION PHENOTYPE.
PubMed=26422139; DOI=10.1371/journal.pone.0138535;
Jain D., Weber G., Eberhard D., Mehana A.E., Eglinger J., Welters A.,
Bartosinska B., Jeruschke K., Weiss J., Paeth G., Ariga H.,
Seufert J., Lammert E.;
"DJ-1 Protects Pancreatic Beta Cells from Cytokine- and
Streptozotocin-Mediated Cell Death.";
PLoS ONE 10:E0138535-E0138535(2015).
-!- FUNCTION: Protein and nucleotide deglycase that catalyzes the
deglycation of the Maillard adducts formed between amino groups of
proteins or nucleotides and reactive carbonyl groups of glyoxals.
Thus, functions as a protein deglycase that repairs
methylglyoxal- and glyoxal-glycated proteins, and releases
repaired proteins and lactate or glycolate, respectively.
Deglycates cysteine, arginine and lysine residues in proteins, and
thus reactivates these proteins by reversing glycation by
glyoxals. Acts on early glycation intermediates (hemithioacetals
and aminocarbinols), preventing the formation of advanced
glycation endproducts (AGE) that cause irreversible damage. Also
functions as a nucleotide deglycase able to repair glycated
guanine in the free nucleotide pool (GTP, GDP, GMP, dGTP) and in
DNA and RNA. Is thus involved in a major nucleotide repair system
named guanine glycation repair (GG repair), dedicated to reversing
methylglyoxal and glyoxal damage via nucleotide sanitization and
direct nucleic acid repair (By similarity). Also displays an
apparent glyoxalase activity that in fact reflects its deglycase
activity (PubMed:22523093). Plays an important role in cell
protection against oxidative stress and cell death acting as
oxidative stress sensor and redox-sensitive chaperone and
protease; functions probably related to its primary function
(PubMed:15784737, PubMed:17015834, PubMed:20800516,
PubMed:21068725). It is involved in neuroprotective mechanisms
like the stabilization of NFE2L2 and PINK1 proteins, male
fertility as a positive regulator of androgen signaling pathway as
well as cell growth and transformation through, for instance, the
modulation of NF-kappa-B signaling pathway (PubMed:17015834,
PubMed:21097510). Eliminates hydrogen peroxide and protects cells
against hydrogen peroxide-induced cell death (PubMed:17766438).
Required for correct mitochondrial morphology and function as well
as for autophagy of dysfunctional mitochondria (PubMed:20186336).
Plays a role in regulating expression or stability of the
mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in
dopaminergic neurons of the substantia nigra pars compacta and
attenuates the oxidative stress induced by calcium entry into the
neurons via L-type channels during pacemaking (PubMed:21068725).
Regulates astrocyte inflammatory responses, may modulate lipid
rafts-dependent endocytosis in astrocytes and neuronal cells
(PubMed:23847046, PubMed:19276172). In pancreatic islets, involved
in the maintenance of mitochondrial reactive oxygen species (ROS)
levels and glucose homeostasis in an age- and diet dependent
manner (PubMed:22611253). Protects pancreatic beta cells from cell
death induced by inflammatory and cytotoxic setting
(PubMed:26422139). Binds to a number of mRNAs containing multiple
copies of GG or CC motifs and partially inhibits their translation
but dissociates following oxidative stress (By similarity). Metal-
binding protein able to bind copper as well as toxic mercury ions,
enhances the cell protection mechanism against induced metal
toxicity (PubMed:23792957). In macrophages, interacts with the
NADPH oxidase subunit NCF1 to direct NADPH oxidase-dependent ROS
production, and protects against sepsis (PubMed:26021615).
{ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:15784737,
ECO:0000269|PubMed:17015834, ECO:0000269|PubMed:17766438,
ECO:0000269|PubMed:19276172, ECO:0000269|PubMed:20186336,
ECO:0000269|PubMed:20800516, ECO:0000269|PubMed:21068725,
ECO:0000269|PubMed:22523093, ECO:0000269|PubMed:22611253,
ECO:0000269|PubMed:23792957, ECO:0000269|PubMed:23847046,
ECO:0000269|PubMed:26021615, ECO:0000269|PubMed:26422139}.
-!- CATALYTIC ACTIVITY: An N(omega)-(1-hydroxy-2-oxopropyl)-[protein]-
L-arginine + H(2)O = a [protein]-L-arginine + (R)-lactate.
{ECO:0000250|UniProtKB:Q99497}.
-!- CATALYTIC ACTIVITY: An N(6)-(1-hydroxy-2-oxopropyl)-[protein]-L-
lysine + H(2)O = a [protein]-L-lysine + (R)-lactate.
{ECO:0000250|UniProtKB:Q99497}.
-!- CATALYTIC ACTIVITY: An S-(1-hydroxy-2-oxopropyl)-[protein]-L-
cysteine + H(2)O = a [protein]-L-cysteine + (R)-lactate.
{ECO:0000250|UniProtKB:Q99497}.
-!- COFACTOR:
Note=Deglycase activity does not require glutathione as a
cofactor, however, glycated glutathione constitutes a PARK7
substrate. {ECO:0000250|UniProtKB:Q99497};
-!- SUBUNIT: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary
complex containing PARK7, EFCAB6/DJBP and AR. Binds to HIPK1 (By
similarity). Interacts (via N-terminus) with OTUD7B
(PubMed:21097510). Interacts with BBS1, CLCF1 and MTERF
(PubMed:21097510). Interacts (via C-terminus) with NCF1; the
interaction is enhanced by LPS and modulates NCF1 phosphorylation
and membrane translocation (PubMed:26021615).
{ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:21097510,
ECO:0000269|PubMed:26021615}.
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23847046};
Lipid-anchor {ECO:0000269|PubMed:23847046}. Cytoplasm
{ECO:0000250|UniProtKB:Q99497}. Membrane raft
{ECO:0000269|PubMed:23847046}. Nucleus
{ECO:0000250|UniProtKB:Q99497}. Mitochondrion
{ECO:0000250|UniProtKB:Q99497}. Note=Under normal conditions,
located predominantly in the cytoplasm and, to a lesser extent, in
the nucleus and mitochondrion. Translocates to the mitochondrion
and subsequently to the nucleus in response to oxidative stress
and exerts an increased cytoprotective effect against oxidative
damage (By similarity). Membrane raft localization in astrocytes
and neuronal cells requires palmitoylation (PubMed:23847046).
{ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:23847046}.
-!- TISSUE SPECIFICITY: Expressed in erythroblasts and in mature red
blood cells from peripheral blood (at protein level)
(PubMed:20800516). In pancreas, expression is higher in islets
than surrounding exocrine tissues (PubMed:22611253).
{ECO:0000269|PubMed:20800516, ECO:0000269|PubMed:22611253}.
-!- DEVELOPMENTAL STAGE: Expression increases during erythroid
development (at protein level) (PubMed:20800516). In pancreatic
islets, expression increases during aging (PubMed:22611253).
{ECO:0000269|PubMed:20800516, ECO:0000269|PubMed:22611253}.
-!- INDUCTION: By hydrogen peroxide. {ECO:0000269|PubMed:14749723}.
-!- PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is essential
for cell-growth promoting activity and transforming activity.
{ECO:0000250|UniProtKB:Q99497}.
-!- PTM: Undergoes cleavage of a C-terminal peptide and subsequent
activation of protease activity in response to oxidative stress.
{ECO:0000250|UniProtKB:Q99497}.
-!- DISRUPTION PHENOTYPE: Increased sensitivity of embryonic cortical
neurons to oxidative stress. Age-dependent increase in
mitochondrial hydrogen peroxide production and reduced
mitochondrial aconitase activity. Down-regulation of Slc25a14 and
Slc25a27, compromised calcium-induced uncoupling and increased
oxidation of mitochondrial matrix proteins specifically in the
dopaminergic neurons of the substantia nigra pars compacta.
Reduced N2el2 protein expression. Impaired mitochondrial function
and morphology with reduced autophagy leading to accumulation of
defective mitochondria. Targeted knockouts in astrocytes exhibit
augmented LPS-induced CRK/p38 phosphorylation and signaling, they
don't stimulate TLR4 endocytosis upon LPS stimulation. Knockout
animals present increased bacterial burdens, reduced local and
systemic inflammation, macrophage paralysis and impaired induction
of proinflammatory cytokines, such as IL6 and TNF, under the
condition of sepsis (PubMed:26021615). Mutants from 12 weeks old,
but not younger, show higher levels of reactive oxygen species
(ROS) and mitochondrial fragmentation in pancreatic islets. They
have lower levels of plasma insulin after glucose challenge,
display glucose intolerance and have reduced beta-cell area.
Younger mutants kept on a high fat diet also show lower levels of
plasma insulin, display glucose intolerance and have reduced beta-
cell area (PubMed:22611253). Animals become diabetic upon multiple
low doses of streptozotocin with reduced insulin concentrations,
higher fasting blood glucose concentrations and higher rates of
beta cell apoptosis compared to wild type (PubMed:26422139).
{ECO:0000269|PubMed:15784737, ECO:0000269|PubMed:17015834,
ECO:0000269|PubMed:17766438, ECO:0000269|PubMed:20186336,
ECO:0000269|PubMed:21068725, ECO:0000269|PubMed:22611253,
ECO:0000269|PubMed:23847046, ECO:0000269|PubMed:26021615,
ECO:0000269|PubMed:26422139}.
-!- SIMILARITY: Belongs to the peptidase C56 family. {ECO:0000305}.
-!- CAUTION: Glyoxylase activity previously reported may reflect in
fact its deglycase activity (PubMed:22523093).
{ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:22523093}.
-!- CAUTION: The protein deglycation activity has been ascribed to a
TRIS buffer artifact by a publication, which has then been
rebutted by clear biochemical experiments showing that PARK7 is a
bona fide deglycase. Deglycase activity is even strengthened by a
novel article that reports nucleotide deglycation activity.
{ECO:0000250|UniProtKB:Q99497}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AB015652; BAA29063.2; -; mRNA.
EMBL; AK146368; BAE27118.1; -; mRNA.
EMBL; AK153948; BAE32271.1; -; mRNA.
EMBL; AK168341; BAE40278.1; -; mRNA.
EMBL; AL607084; CAM19230.1; -; Genomic_DNA.
EMBL; BC002187; AAH02187.1; -; mRNA.
CCDS; CCDS18975.1; -.
RefSeq; NP_065594.2; NM_020569.3.
UniGene; Mm.277349; -.
ProteinModelPortal; Q99LX0; -.
SMR; Q99LX0; -.
BioGrid; 208257; 15.
IntAct; Q99LX0; 9.
MINT; MINT-1869265; -.
STRING; 10090.ENSMUSP00000030805; -.
MEROPS; C56.002; -.
iPTMnet; Q99LX0; -.
PhosphoSitePlus; Q99LX0; -.
SwissPalm; Q99LX0; -.
REPRODUCTION-2DPAGE; Q99LX0; -.
UCD-2DPAGE; Q99LX0; -.
EPD; Q99LX0; -.
MaxQB; Q99LX0; -.
PaxDb; Q99LX0; -.
PeptideAtlas; Q99LX0; -.
PRIDE; Q99LX0; -.
TopDownProteomics; Q99LX0; -.
Ensembl; ENSMUST00000030805; ENSMUSP00000030805; ENSMUSG00000028964.
Ensembl; ENSMUST00000105673; ENSMUSP00000101298; ENSMUSG00000028964.
Ensembl; ENSMUST00000105674; ENSMUSP00000101299; ENSMUSG00000028964.
Ensembl; ENSMUST00000105675; ENSMUSP00000101300; ENSMUSG00000028964.
GeneID; 57320; -.
KEGG; mmu:57320; -.
UCSC; uc008vxz.2; mouse.
CTD; 11315; -.
MGI; MGI:2135637; Park7.
eggNOG; KOG2764; Eukaryota.
eggNOG; COG0693; LUCA.
GeneTree; ENSGT00390000001231; -.
HOGENOM; HOG000063194; -.
HOVERGEN; HBG053511; -.
InParanoid; Q99LX0; -.
KO; K05687; -.
OMA; TCYPGFE; -.
OrthoDB; EOG091G12NS; -.
PhylomeDB; Q99LX0; -.
TreeFam; TF300119; -.
PRO; PR:Q99LX0; -.
Proteomes; UP000000589; Chromosome 4.
Bgee; ENSMUSG00000028964; -.
ExpressionAtlas; Q99LX0; baseline and differential.
Genevisible; Q99LX0; MM.
GO; GO:0044297; C:cell body; IDA:ParkinsonsUK-UCL.
GO; GO:0005913; C:cell-cell adherens junction; ISO:MGI.
GO; GO:0000785; C:chromatin; ISO:MGI.
GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
GO; GO:0070062; C:extracellular exosome; ISO:MGI.
GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
GO; GO:0005758; C:mitochondrial intermembrane space; IDA:ParkinsonsUK-UCL.
GO; GO:0005759; C:mitochondrial matrix; IDA:ParkinsonsUK-UCL.
GO; GO:0005747; C:mitochondrial respiratory chain complex I; IEA:Ensembl.
GO; GO:0005739; C:mitochondrion; IDA:ParkinsonsUK-UCL.
GO; GO:0043005; C:neuron projection; IDA:ParkinsonsUK-UCL.
GO; GO:0005634; C:nucleus; IDA:MGI.
GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0016605; C:PML body; ISO:MGI.
GO; GO:0098793; C:presynapse; IEA:GOC.
GO; GO:0050681; F:androgen receptor binding; ISO:MGI.
GO; GO:0045296; F:cadherin binding; ISO:MGI.
GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
GO; GO:1903135; F:cupric ion binding; ISO:MGI.
GO; GO:1903136; F:cuprous ion binding; ISO:MGI.
GO; GO:0019955; F:cytokine binding; ISO:MGI.
GO; GO:0019899; F:enzyme binding; ISO:MGI.
GO; GO:0042802; F:identical protein binding; ISO:MGI.
GO; GO:0019900; F:kinase binding; ISO:MGI.
GO; GO:0036478; F:L-dopa decarboxylase activator activity; ISO:MGI.
GO; GO:0045340; F:mercury ion binding; ISS:UniProtKB.
GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
GO; GO:0016684; F:oxidoreductase activity, acting on peroxide as acceptor; ISO:MGI.
GO; GO:0008233; F:peptidase activity; ISS:UniProtKB.
GO; GO:0051920; F:peroxiredoxin activity; IMP:MGI.
GO; GO:0036524; F:protein deglycase activity; ISO:MGI.
GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
GO; GO:0005102; F:receptor binding; ISO:MGI.
GO; GO:0070491; F:repressing transcription factor binding; ISO:MGI.
GO; GO:0003723; F:RNA binding; TAS:MGI.
GO; GO:0097110; F:scaffold protein binding; ISO:MGI.
GO; GO:0044388; F:small protein activating enzyme binding; ISO:MGI.
GO; GO:0016532; F:superoxide dismutase copper chaperone activity; ISO:MGI.
GO; GO:0003713; F:transcription coactivator activity; ISO:MGI.
GO; GO:0008134; F:transcription factor binding; ISO:MGI.
GO; GO:0036470; F:tyrosine 3-monooxygenase activator activity; ISO:MGI.
GO; GO:0044390; F:ubiquitin-like protein conjugating enzyme binding; ISO:MGI.
GO; GO:1990381; F:ubiquitin-specific protease binding; ISO:MGI.
GO; GO:0008344; P:adult locomotory behavior; IMP:MGI.
GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
GO; GO:0008283; P:cell proliferation; TAS:MGI.
GO; GO:0036471; P:cellular response to glyoxal; IMP:ParkinsonsUK-UCL.
GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:UniProtKB.
GO; GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB.
GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:MGI.
GO; GO:0010273; P:detoxification of copper ion; IMP:UniProtKB.
GO; GO:0050787; P:detoxification of mercury ion; IMP:UniProtKB.
GO; GO:0006281; P:DNA repair; ISS:UniProtKB.
GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IMP:MGI.
GO; GO:0018323; P:enzyme active site formation via L-cysteine sulfinic acid; IMP:ParkinsonsUK-UCL.
GO; GO:0042593; P:glucose homeostasis; IMP:UniProtKB.
GO; GO:0036531; P:glutathione deglycation; ISO:MGI.
GO; GO:0046295; P:glycolate biosynthetic process; IDA:ParkinsonsUK-UCL.
GO; GO:1903189; P:glyoxal metabolic process; IDA:ParkinsonsUK-UCL.
GO; GO:0106044; P:guanine deglycation; ISS:UniProtKB.
GO; GO:0106046; P:guanine deglycation, glyoxal removal; ISS:UniProtKB.
GO; GO:0106045; P:guanine deglycation, methylglyoxal removal; ISS:UniProtKB.
GO; GO:0042743; P:hydrogen peroxide metabolic process; IMP:MGI.
GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
GO; GO:0030073; P:insulin secretion; IMP:UniProtKB.
GO; GO:0019249; P:lactate biosynthetic process; ISO:MGI.
GO; GO:0051899; P:membrane depolarization; IMP:MGI.
GO; GO:0060081; P:membrane hyperpolarization; IMP:MGI.
GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB.
GO; GO:0043066; P:negative regulation of apoptotic process; IMP:ParkinsonsUK-UCL.
GO; GO:0060548; P:negative regulation of cell death; IMP:UniProtKB.
GO; GO:2001268; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; ISO:MGI.
GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL.
GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; ISO:MGI.
GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.
GO; GO:1903206; P:negative regulation of hydrogen peroxide-induced cell death; ISO:MGI.
GO; GO:1903208; P:negative regulation of hydrogen peroxide-induced neuron death; IMP:ParkinsonsUK-UCL.
GO; GO:1903384; P:negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL.
GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:MGI.
GO; GO:1901215; P:negative regulation of neuron death; ISO:MGI.
GO; GO:1905259; P:negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway; ISO:MGI.
GO; GO:1903202; P:negative regulation of oxidative stress-induced cell death; ISO:MGI.
GO; GO:1903204; P:negative regulation of oxidative stress-induced neuron death; IMP:ParkinsonsUK-UCL.
GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; ISO:MGI.
GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:MGI.
GO; GO:1901984; P:negative regulation of protein acetylation; ISO:MGI.
GO; GO:0032091; P:negative regulation of protein binding; ISS:UniProtKB.
GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:ParkinsonsUK-UCL.
GO; GO:0046826; P:negative regulation of protein export from nucleus; ISO:MGI.
GO; GO:1903094; P:negative regulation of protein K48-linked deubiquitination; ISO:MGI.
GO; GO:0006469; P:negative regulation of protein kinase activity; ISO:MGI.
GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:MGI.
GO; GO:0033234; P:negative regulation of protein sumoylation; ISO:MGI.
GO; GO:0031397; P:negative regulation of protein ubiquitination; IMP:ParkinsonsUK-UCL.
GO; GO:1903427; P:negative regulation of reactive oxygen species biosynthetic process; IMP:UniProtKB.
GO; GO:1903122; P:negative regulation of TRAIL-activated apoptotic signaling pathway; ISO:MGI.
GO; GO:0051444; P:negative regulation of ubiquitin-protein transferase activity; ISO:MGI.
GO; GO:2000157; P:negative regulation of ubiquitin-specific protease activity; ISO:MGI.
GO; GO:0036527; P:peptidyl-arginine deglycation; ISO:MGI.
GO; GO:0036526; P:peptidyl-cysteine deglycation; ISO:MGI.
GO; GO:0036528; P:peptidyl-lysine deglycation; ISO:MGI.
GO; GO:0002866; P:positive regulation of acute inflammatory response to antigenic stimulus; IMP:UniProtKB.
GO; GO:2000825; P:positive regulation of androgen receptor activity; ISO:MGI.
GO; GO:1903181; P:positive regulation of dopamine biosynthetic process; ISO:MGI.
GO; GO:0010628; P:positive regulation of gene expression; IMP:ParkinsonsUK-UCL.
GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:MGI.
GO; GO:1903197; P:positive regulation of L-dopa biosynthetic process; ISO:MGI.
GO; GO:1903200; P:positive regulation of L-dopa decarboxylase activity; ISO:MGI.
GO; GO:1902958; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; IMP:ParkinsonsUK-UCL.
GO; GO:0033864; P:positive regulation of NAD(P)H oxidase activity; IMP:UniProtKB.
GO; GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; IMP:UniProtKB.
GO; GO:1902177; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; IMP:MGI.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:MGI.
GO; GO:0090073; P:positive regulation of protein homodimerization activity; ISO:MGI.
GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:MGI.
GO; GO:1903168; P:positive regulation of pyrroline-5-carboxylate reductase activity; ISO:MGI.
GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IDA:MGI.
GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISO:MGI.
GO; GO:1901671; P:positive regulation of superoxide dismutase activity; ISO:MGI.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:ParkinsonsUK-UCL.
GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISO:MGI.
GO; GO:1903178; P:positive regulation of tyrosine 3-monooxygenase activity; ISO:MGI.
GO; GO:0036529; P:protein deglycation, glyoxal removal; ISO:MGI.
GO; GO:0006517; P:protein deglycosylation; ISS:UniProtKB.
GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
GO; GO:0060765; P:regulation of androgen receptor signaling pathway; ISO:MGI.
GO; GO:0050727; P:regulation of inflammatory response; IMP:UniProtKB.
GO; GO:0051881; P:regulation of mitochondrial membrane potential; ISO:MGI.
GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB.
GO; GO:0042542; P:response to hydrogen peroxide; IDA:MGI.
GO; GO:0007338; P:single fertilization; IEA:UniProtKB-KW.
GO; GO:0001963; P:synaptic transmission, dopaminergic; IMP:MGI.
Gene3D; 3.40.50.880; -; 1.
InterPro; IPR029062; Class_I_gatase-like.
InterPro; IPR002818; DJ-1/PfpI.
InterPro; IPR006287; DJ1.
Pfam; PF01965; DJ-1_PfpI; 1.
SUPFAM; SSF52317; SSF52317; 1.
TIGRFAMs; TIGR01383; not_thiJ; 1.
1: Evidence at protein level;
Acetylation; Autophagy; Cell membrane; Chaperone; Complete proteome;
Copper; Cytoplasm; Direct protein sequencing; DNA damage; DNA repair;
Fertilization; Hydrolase; Inflammatory response; Isopeptide bond;
Lipoprotein; Membrane; Mitochondrion; Nucleus; Oxidation; Palmitate;
Phosphoprotein; Protease; Reference proteome; RNA-binding;
Stress response; Tumor suppressor; Ubl conjugation; Zymogen.
INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:Q99497}.
CHAIN 2 ? Protein/nucleic acid deglycase DJ-1.
/FTId=PRO_0000157850.
PROPEP ? 189 Removed in mature form.
/FTId=PRO_0000405560.
ACT_SITE 106 106 Nucleophile.
{ECO:0000250|UniProtKB:Q99497}.
ACT_SITE 126 126 {ECO:0000250|UniProtKB:Q99497}.
MOD_RES 2 2 N-acetylalanine.
{ECO:0000250|UniProtKB:Q99497}.
MOD_RES 67 67 Phosphotyrosine.
{ECO:0000250|UniProtKB:Q99497}.
MOD_RES 106 106 Cysteine sulfinic acid (-SO2H);
alternate.
{ECO:0000250|UniProtKB:Q99497}.
MOD_RES 148 148 N6-acetyllysine.
{ECO:0000244|PubMed:23806337}.
MOD_RES 182 182 N6-succinyllysine.
{ECO:0000244|PubMed:23806337}.
LIPID 46 46 S-palmitoyl cysteine.
{ECO:0000250|UniProtKB:Q99497}.
LIPID 53 53 S-palmitoyl cysteine.
{ECO:0000250|UniProtKB:Q99497}.
LIPID 106 106 S-palmitoyl cysteine; alternate.
{ECO:0000250|UniProtKB:Q99497}.
CROSSLNK 130 130 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO).
{ECO:0000250|UniProtKB:Q99497}.
MUTAGEN 46 46 C->A: Sulfinic acid detected following
treatment with hydrogen peroxide.
{ECO:0000269|PubMed:17766438}.
MUTAGEN 53 53 C->A: Sulfinic acid detected following
treatment with hydrogen peroxide.
{ECO:0000269|PubMed:17766438}.
MUTAGEN 106 106 C->A: No sulfinic acid detected following
treatment with hydrogen peroxide.
{ECO:0000269|PubMed:17766438}.
CONFLICT 127 127 P -> T (in Ref. 2; BAE40278).
{ECO:0000305}.
SEQUENCE 189 AA; 20021 MW; 877C825CCA07468F CRC64;
MASKRALVIL AKGAEEMETV IPVDVMRRAG IKVTVAGLAG KDPVQCSRDV MICPDTSLED
AKTQGPYDVV VLPGGNLGAQ NLSESPMVKE ILKEQESRKG LIAAICAGPT ALLAHEVGFG
CKVTTHPLAK DKMMNGSHYS YSESRVEKDG LILTSRGPGT SFEFALAIVE ALVGKDMANQ
VKAPLVLKD


Related products :

Catalog number Product name Quantity
EIAAB32390 E3 ubiquitin-protein ligase parkin,Homo sapiens,Human,PARK2,Parkinson disease protein 2,Parkinson juvenile disease protein 2,PRKN
EIAAB29908 Cap1,Contraception-associated protein 1,Fertility protein SP22,Park7,Parkinson disease protein 7 homolog,Protein CAP1,Protein DJ-1,Rat,Rattus norvegicus
EIAAB29910 Mouse,Mus musculus,Park7,Parkinson disease protein 7 homolog,Protein DJ-1
EIAAB29909 Bos taurus,Bovine,PARK7,Parkinson disease protein 7 homolog,Protein DJ-1
EIAAB29911 Chicken,Gallus gallus,PARK7,Parkinson disease protein 7 homolog,Protein DJ-1
EIAAB29912 Homo sapiens,Human,Oncogene DJ1,PARK7,Parkinson disease protein 7,Protein DJ-1
orb81255 Human Parkinson Disease Protein 7 protein Proteins 5
E2138m ELISA kit 14 kDa submandibular gland protein,GCDFP-15,Gross cystic disease fluid protein 15,Mouse,Mus musculus,Pip,Prolactin-induced protein,Prolactin-inducible protein homolog,SMGP 96T
U2138m CLIA kit 14 kDa submandibular gland protein,GCDFP-15,Gross cystic disease fluid protein 15,Mouse,Mus musculus,Pip,Prolactin-induced protein,Prolactin-inducible protein homolog,SMGP 96T
U2138m CLIA 14 kDa submandibular gland protein,GCDFP-15,Gross cystic disease fluid protein 15,Mouse,Mus musculus,Pip,Prolactin-induced protein,Prolactin-inducible protein homolog,SMGP 96T
E2138m ELISA 14 kDa submandibular gland protein,GCDFP-15,Gross cystic disease fluid protein 15,Mouse,Mus musculus,Pip,Prolactin-induced protein,Prolactin-inducible protein homolog,SMGP 96T
RPR-575 Recombinant Human Parkinson Disease Protein 7 5
PRO-575 Recombinant Human Parkinson Disease Protein 7 5µg
PRO-575 Recombinant Human Parkinson Disease Protein 7 1mg
PRO-575 Recombinant Human Parkinson Disease Protein 7 20µg
pro-575 Recombinant Human Parkinson Disease Protein 7 20
pro-575 Recombinant Human Parkinson Disease Protein 7 1mg
pro-575 Recombinant Human Parkinson Disease Protein 7 5
orb81255 Human Parkinson Disease Protein 7 protein PARK7 Human Recombinant fused to N-terminal His-Tag produced in E.coli is a single, non-glycosylated polypeptide chain containing 225 amino acids and having a 5
7-05801 Recombinant Human Parkinson Disease Protein 7 20
228-11203-3 Recombinant Human Parkinson Disease Protein 7 1 mg
ant-317 Mouse Anti Human Parkinson Disease Protein 7 5
P1236035Par Total Protein _ Parkinson's Disease Brain 1 mg
228-11203-2 Recombinant Human Parkinson Disease Protein 7 20
CF59 Parkinson Juvenile Disease Protein 2 PARK2 500


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur